Cancer is one of the most frequently diagnosed malignant diseases worldwide, posing a
serious, long-term threat to patients' health and life. Systemic chemotherapy remains the first …

The acquisition of cancer cell resistance to conventional chemotherapeutics is considered
the major driver of treatment failure and disease recurrence in most solid and hematological …

Epithelial-to-mesenchymal transition (EMT) is a process that involves the transformation of
polarized epithelial cells to attain a mesenchymal phenotype that presents an elevated …

DNA methylation is one of the main epigenetic mechanisms in cancer development and
progression. Aberrant DNA methylation of CpG islands within promoter regions contributes …

Liver is an important organ in body that performs vital functions such as detoxification. Liver
is susceptible to development of cancers, and hepatocellular carcinoma (HCC) is among …

Hepatocellular carcinoma (HCC) is the leading cause of cancer-related death in people, and
a common primary liver cancer. Lacking early diagnosis and a high recurrence rate after …

Hepatocellular carcinoma (HCC) is primary liver cancer, frequently diagnosed at advanced
stages with limited therapeutic options. MicroRNAs (miRNAs) regulate target gene …

Hepatocellular carcinoma (HCC) remains a major health problem worldwide, being the
leading cause of cancer-related deaths, with limited treatment options, especially in its …

Hepatocellular carcinoma (HCC) is a significant contributor to cancer-related deaths in the
world. The development and progression of HCC are closely correlated with the abnormal …

Simple Summary MicroRNAs (miRNAs) are small biomolecules that can indicate the
presence of certain diseases, including cancer. They are stable and can be easily detected …